CN Stock MarketDetailed Quotes

Guangzhou LBP Medicine Science & Technology (688393)

Watchlist
  • 20.67
  • +0.58+2.89%
Noon Break Jun 5 11:29 CST
1.93BMarket Cap-51.16P/E (TTM)

Guangzhou LBP Medicine Science & Technology (688393) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Self-made product275.14M79.88%
Service income33.67M9.77%
Outsourcing products28.45M8.26%
Other business7.18M2.08%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
In vitro diagnostic product337.27M97.92%
Other business7.18M2.08%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China97.83M28.40%
South China84.87M24.64%
North China47.46M13.78%
Southwest39.4M11.44%
Central China35.85M10.41%
Northwest24.8M7.20%
Other business7.18M2.08%
Northeast China5.65M1.64%
Overseas1.41M0.41%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More